Suchergebnisse - "Chazallon, Corine"

PubPharm (32)

1

Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis : Findings From Reflate TB2 Randomized Trial

enthalten in: Open forum infectious diseases | 2024

von Coelho, L. | Chazallon, C. | Laureillard, D. | +14

2

Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial

enthalten in: ResearchSquare.com | 2023

von Lacombe, K. | Moh, R. | Chazallon, C. | +20

3

Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries

enthalten in: AIDS (London, England) | 2023

von De Castro, N. | Chazallon, C. | Brites, C. | +11

4

Late-onset neonatal sepsis : genetic differences by sex and involvement of the NOTCH pathway

enthalten in: Pediatric research | 2023

von Ciesielski, T. | Zhang, X. | Tacconelli, A. | +76

5

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

enthalten in: Open forum infectious diseases | 2022

von De Castro, N. | Chazallon, C. | N'takpe, J. | +16

6

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM) : study protocol for a phase III randomized controlled trial

enthalten in: Trials | 2022

von Maitre, T. | Bonnet, M. | Calmy, A. | +18

7

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

enthalten in: Trials | 2022

von Maitre, T. | Bonnet, M. | Calmy, A. | +18

8

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

enthalten in: Trials | 2022

von Maitre, T. | Bonnet, M. | Calmy, A. | +18

9

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2) : an open-label, non-inferiority, randomised, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2021

von De Castro, N. | Marcy, O. | Chazallon, C. | +117

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):748-749. - PMID 33667407

10

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1) : A randomised controlled trial

enthalten in: PloS one | 2020

von Lutsar, I. | Chazallon, C. | Trafojer, U. | +28